Submission to Health Canada on their notice of intent to amend regulations to address health product shortages in Canada

Employers and their insurers are driven by providing healthcare supports that ensure their employees remain stable on treatments that work for them.

Employees receive value from their benefit plans when there are few to no disruptions in continuity. As a key participant and stakeholder in the provision of healthcare in Canada, the CLHIA has provided Health Canada with the following submission on the impact of shortages on private plans, and recommendations for their consideration as they seek to amend regulations in this area.

Health Canada Consultation on Drug and Device Shortages.pdf